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CYP199A4, a cytochrome P450 enzyme from Rhodopseudomonas palustris HaA2, is able to 







The cytochrome P450 enzyme CYP199A4, from Rhodopseudomonas palustris strain HaA2, 
can efficiently demethylate 4-methoxybenzoic acid via hemiacetal formation and subsequent 
elimination of formaldehyde. Oxidative demethylation of a methoxy group para to the 
carboxyl moiety is strongly favoured over reaction at one in the ortho or meta positions. 
Dimethoxybenzoic acids containing a para-methoxy group were also efficiently 
demethylated exclusively at the para position. The presence of additional methoxy 
substituents reduces the substrate binding affinity and the activity compared to 4-
methoxybenzoic acid. The addition of the smaller hydroxy group to the ortho or meta 
positions or of a nitrogen heteroatom in the aromatic ring of the 4-methoxybenzoate skeleton 
was better tolerated by the enzyme and these analogues were also readily demethylated. 
There was no evidence of methylenedioxy ring formation with 3-hydroxy-4-methoxybenzoic 
acid, an activity which is observed with certain plant CYP enzymes with analogous 
substrates. CYP199A4 is also able to deprotect the methylenedioxy group of 3,4-
(methylenedioxy)benzoic acid to yield 3,4-dihydroxybenzoic acid and formic acid. This 
study defines the substrate range of CYP199A4 and reveals that substrates without a para 
substituent are not oxidised with any significant activity. Therefore para-substituted benzoic 
acids are ideal substrate scaffolds for the CYP199A4 enzyme and will aid in the design of 
optimised probes to investigate the mechanism of this class of enzymes. It also allows an 
assessment of the potential of CYP199A4 for synthetic biocatalytic processes involving 













Cytochrome P450 (CYP) enzymes are heme-dependent monooxygenases with physiological 
roles that include hormone and secondary metabolite biosynthesis, as well as xenobiotic 
metabolism.1-3 CYP enzymes primarily catalyse the insertion of an oxygen atom from 
dioxygen into carbon-hydrogen bonds of organic molecules. Mechanistically, hydrogen 
abstraction by Compound I is followed by oxygen rebound to give the hydroxylated 
compound.4, 5 Many other types of activity are also known and include C–C bond cleavage 
and formation, oxidative dealkylation and various ring alterations.2, 3, 6, 7 The stable, soluble 
nature of bacterial CYP enzymes and the wide range of compounds they oxidise are of 
interest for applications in synthesis involving C–H bond oxidation.8, 9 The ability to engineer 
these bacterial CYP enzymes via rational or random methods can further enhance their 
activities and broaden their substrate range.8, 10 A detailed knowledge of the enzyme-substrate 
interactions is critical in these efforts in order to maximise the catalytic efficiency of the CYP 
systems and to achieve the turnover numbers required for synthetic applications. 
Rhodopseudomonas palustris is a family of purple photosynthetic bacteria that are 
isolated in temperate, aquatic sediments and possess extraordinary metabolic versatility. 
Bacteria classified as Rhodopseudomonas spp. can grow with or without light or oxygen, fix 
nitrogen and have a wide range of biodegradative abilities.11 Studies have shown that 
different Rhodopseudomonas species share many characteristics but different strains have 
unique sets of functional genes to take advantage of the microenvironment in which they are 
found. We recently reported the properties of the complete CYP199A4 class I P450 system, 
from the R. palustris strain HaA2, which uses an electron transfer chain consisting of a [2Fe-
2S] ferredoxin (HaPux) and a flavin-dependent ferredoxin reductase (HaPuR) to mediate 
heme reduction by NADH.12-17 CYP199A4 and the closely related CYP199A2 enzyme, from 
R. palustris strain CGA009, have high affinities for 4-methoxybenzoic acid.12, 13, 17 The 
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benzoic acid skeleton is important for binding and replacing it with a benzyl alcohol or a 
benzaldehyde reduces the strength of substrate binding dramatically.12, 18 Altering the 
benzene ring to a saturated cyclohexyl system or removal of the substituent at the para-
position both have a deleterious effect on substrate binding and activity.12, 18 
In addition to 4-methoxybenzoic acid, CYP199A4 can bind and O-demethylate 3,4-
dimethoxybenzoic acid (veratric acid) solely at the 4-methoxy group to yield 3-methoxy-4-
hydroxybenzoic acid (vanillic acid). However the spin state shift observed upon substrate 
binding is reduced, the binding is not as tight and the activity is lower.17 CYP199 enzymes 
have also been reported to be biocatalysts for the oxyfunctionalisation of various aromatic 
carboxylic acids including 2-naphthoic acid, indole-6-carboxylic acid and cinnamic acids.19-21 
Recently mutant forms of the CYP199A2 enzyme have been shown to catalyse the oxidation 
of benzyl alcohols and phenols using a whole-cell oxidation system. However detailed 
analysis of the substrate-enzyme interactions were not presented.22 
The crystal structure of substrate-free and 4-methoxybenzoic acid-bound forms of 
CYP199A4 have been determined (PDB: 4DNZ and 4DO1).13, 18, 23 In the substrate-bound 
structures the substrate carboxylate group interacts with polar and basic amino acid side 
chains while hydrophobic interactions with the benzene ring help hold the substrate in 
position. These interactions account for the efficiency and substrate specificity of the 
enzyme. In the crystal structure of 4-methoxybenzoic acid-bound CYP199A4, the substrate 
carboxylate group forms hydrogen bonds directly to the side chains of Arg92, Ser95 and 
Ser244 and, via a bridging water molecule, Arg243. The addition of the substrate triggers 
movement in these residues and is accompanied by the binding of a chloride ion.23 These 
structural changes cap the entrance to the active site and protect the heme from the external 
solvent. The methyl group of the para-methoxy substituent is oriented towards the heme iron 
(3.9 Å), which is consistent with exclusive attack at this position, leading to demethylation to 
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form 4-hydroxybenzoic acid. The crystal structure of CYP199A4 with 3,4-dimethoxybenzoic 
acid (PDB: 4EGN) reveals that the introduction of a methoxy group at the meta position 
causes steric clashes with active site residues, Phe182 and Phe185, which presumably leads 
to the reduced efficiency of binding and therefore activity.18  
The chemical removal of methyl protecting groups often requires harsh conditions 
and unselective reagents.24 Alkyl methyl ethers usually require a Lewis acid and a 
nucleophile for efficient demethylation while aryl methyl ethers, such as 4-methoxybenzoic 
acid, can be demethylated in the absence of the Lewis acid. However the CYP enzyme-
catalysed O-demethylation reaction proceeds under ambient conditions. CYP enzymes are 
attractive targets for carrying out selective oxidative demethylation and therefore the 
deprotection of methoxy groups under mild conditions. 
Here we compare the binding and kinetic properties of CYP199A4 with selected 
substituted methoxybenzoic acid substrates. These studies will provide a basis for 
understanding how benzoic acids with differently sized substituents at the ortho- and meta-
positions or a heteroatom in the benzene ring interact with and are oxidized by the enzyme. 
We also investigate if CYP199A4 is able to catalyse the demethenylation of 3,4-
(methylenedioxy)benzoic acid. This will provide a basis for the future synthesis of small 
molecule probes designed to investigate the subtleties of the mechanism of action of CYP 




Results and discussion 
Substrate binding studies on the CYP199A4 system 
We had shown previously that binding of 4-methoxybenzoic acid to CYP199A4 induces a 
≥ 95% Type I spin state shift (Table 1) while 3,4-dimethoxybenzoic acid (veratric acid) only 
shifts the spin state to 70% high-spin.17 Binding of 3,4-dimethoxybenzoic acid to CYP199A4 
was also two orders of magnitude (29.5 M) weaker compared to 4-methoxybenzoic acid 
(0.28 M). A comparison of the crystal structures of substrate-bound forms of CYP199A4 
with these two substrates reveals that the phenyl rings, the carboxylate group and 4-methoxy 
substituent are, to all practical purposes, superimposable. The 3-methoxy substituent of 3,4-
dimethoxybenzoic acid points away from the heme and it makes contact with the benzene 
ring of Phe182 and Phe185. This causes Phe182 to move, resulting in changes in the location 
of the side chains of Leu396 and Asp251. These steric clashes presumably are the main 
contributing factor to the weaker binding of this substrate and the relative location of the two 
methoxy groups to the heme iron provides a compelling rationale for demethylation only at 
the para substituent. In this work a range of substituted benzoic acid derivatives was tested to 
further probe the limits of substrate shape and electronic structure on CYP199A4 substrate 
binding and activity (Fig. 1a). 
2-Methoxy- and 3-methoxybenzoic acid both induced a significantly lower spin state 
shift to the high-spin form than 4-methoxybenzoic acid, with the 3-methoxy variant giving a 
greater shift than the 2-methoxy isomer (Table 1, Fig. 1b and Fig. S1). Benzoic acid bound to 
CYP199A4 and induced a spin state shift of 30% which is higher than that induced by 2-
methoxybenzoic acid but lower than those of 3- and 4-methooxybenzoic acids. 
Dimethoxybenzoic acids which lack the substituent at the para-position also induced 
minimal spin state shifts in CYP199A4, though that of 3,5-dimethoxybenzoic acid was higher 
than that of 2,5-dimethoxybenzoic acid (Table 1 and Fig. S1). This highlights that the para-
7 
 
methoxy substituent, or equivalent, is a requirement for removal of the water bound to the 
heme iron when substrate binds. This agrees with previous data obtained for CYP199A2 
where the addition of benzoic acid induces a lower shift than 4-methoxybenzoic acid and 
both 2-chlorobenzoic acid and 3-chlorobenzoic acid bind poorly compared to 4-
chlorobenzoic acid.12 The para-methoxy group of 4-methoxybenzoic acid interacts with 
Phe182 and Phe298 and is held over the heme in an ideal position for CH bond 
abstraction.23 These interactions could stabilise the binding of this substrate over benzoic acid 
alone. The lack of the para-methoxy group and the presence of groups at the ortho- or meta- 
positions, which could result in steric clashes with active site amino acids or the heme, 
reduce the binding affinity of these benzoic acids. Benzoic acids which only contain a 
substituent at the para-position may also have more freedom to rotate in the substrate binding 
pocket of CYP199A4 resulting in more favourable binding. As the presence of a substituent 
para to the carboxylic acid was found to be important for substrate binding we decided to 
explore the effect of additional substituents at the ortho- and meta-positions. Therefore we 
studied the binding of differently substituted 4-methoxybenzoic acids (Fig. 1a). 
2,4-Dimethoxy-, 2-hydroxy-4-methoxy and 3-hydroxy-4-methoxy-benzoic acids 
induced a spin state shift of  90%, all of which are greater than that observed with 3,4-
dimethoxybenzoic acid (Table 1, Fig. 1 and Fig. S1). 3-Hydroxy-4-methoxy benzoic acid 
with the smaller hydroxy group at the meta-position appears to be better accommodated in 
the substrate binding pocket than 3,4-dimethoxybenzoic acid which has a larger methoxy 
moiety at the analogous position. In addition, having the methoxy group ortho to the 
carboxylate group, as in 2,4-dimethoxybenzoic acid, appears not to disrupt binding as much 
as the 3,4-dimethoxybenzoic acid. We also investigated the effect of inserting a heteroatom at 
the meta-position of the benzene ring. 6-Methoxynicotinic acid induced a  95% type I spin 
state shift (Fig. S1), indicating that a nitrogen-containing aromatic ring does not dramatically 
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affect substrate binding. These substrates may be orientated with the nitrogen, hydroxy or 
methoxy moiety either directed towards the heme ring or pointing at the Phe182 and Phe185 
residues (or in a mixture of both orientations). However the large spin state shift infers the 
nitrogen or the hydroxy substituents do not interfere with the dissociation of the 6th water 
ligand in whichever orientation it is bound. 
The size of the substrate and the nature of the substitutions which can bind in the 
active site of CYP199A4 were further tested by investigating 3,4-(methylenedioxy)benzoic 
acid, which is structurally related to both 3,4-dimethoxybenzoic acid and 3-hydroxy-4-
methoxybenzoic acid. This substrate induces a shift to 70% high-spin which is comparable to 
that observed with the larger 3,4-dimethoxybenzoic acid but lower than that observed with 3-
hydroxy-4-methoxybenzoic acid (Table 1 and Fig. 1). The methylenedioxy group may be 
held with the methylene group located in a similar position to the methyl of the para-
methoxy substituent of 3,4-dimethoxybenzoic acid where the 3-methoxy group points away 
from the heme and towards Phe182 as revealed in the crystal structure of 3,4-
dimethoxybenzoic acid–bound CYP199A4 (PDB: 4EGN); this could be the reason for the 
reduced spin state shift.18 Alternatively, the methylenedioxy five membered ring may be 
orientated towards the heme in a similar position to that of the pyrole ring of indole-6-
carboxylic acid-bound CYP199A4 (PDB: EGO, binding of this substrate induces a 20% shift 
to the high-spin form).18 
While the spin state shift gives an indication of substrate binding neatly in the 
substrate binding pocket it does not provide detailed information on how tightly the substrate 
may be bound. To further analyse substrate binding, the dissociation constant (Kd) was 
determined for each substrate using UV-Vis titration experiments (Table 1, Fig. 2 and S2). 6-
Methoxynicotinic acid binds tightly to CYP199A4 (Kd = 0.46 μM), highlighting that the 
heterocyclic ring does not significantly impair binding. 3-Hydroxy-4-methoxybenzoic acid 
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bound less tightly (Kd = 1.7 μM) than 4-methoxybenzoic acid and 6-methoxynicotinic acid 
but more tightly than 3,4-dimethoxybenzoic acid, confirming that the smaller hydroxyl group 
at this position is better accommodated in the active site of CYP199A4. 2-Hydroxy-4-
methoxybenzoic acid bound as tightly as 4-methoxybenzoic acid. Despite the higher spin 
state shift observed on substrate binding, 2,4-dimethoxybenzoic acid bound more weakly 
than 3,4-dimethoxybenzoic acid and the larger methoxy substituent at the ortho-position must 
also impair substrate binding though not dissociation of the water ligand from the heme iron 
(Table 1 and Fig. 2). The most likely cause of the reduced binding affinity is steric clashes 
with amino acids in the active site of CYP199A4. 
3,4-(Methylenedioxy)benzoic acid bound more tightly than both 3,4-
dimethoxybenzoic acid and 3-hydroxy-4-methoxybenzoic acid suggesting improved 
interactions with the substrate binding pocket despite the lower spin state shift observed 
(Table 1 and Fig. S2). This may be due to combination of the more hydrophobic 
methylenedioxy ring, compared to the hydroxyl group in 3-hydroxy-4-methoxybenzoic acid, 
and the smaller size of the substrate compared to 3,4-dimethoxybenzoic acid. 3-
Methoxybenzoic acid bound less tightly to CYP199A4 than any of the substrates which 
contain a methoxy group at the para-position (Table 1). 3-Methoxybenzoic acid bound to 
CYP199A4 two orders of magnitude more weakly than 4-methoxybenzoic acid and, despite 
its higher spin state shift, less tightly than benzoic acid suggesting the 3-methoxy group 
interacts less favourably with the substrate binding pocket. The binding of 3,5-
dimethoxybenzoic acid was 20-fold weaker than 3-methoxybenzoic acid in line with the low 
spin state shift observed. The negligible spin state shifts induced by the 2-methoxybenzoic 
and 2,5-dimethoxybenzoic acids prevented the accurate determination of the dissociation 
constant (Kd > 1.5 mM).  
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Overall the data indicates that a substituent para to the carboxylate moiety is 
beneficial for substrate binding and that additional, preferably smaller, substituents can be 
accommodated at the ortho- and meta-positions.  
Activity and product formation assays 
The rates of NADH oxidation and product formation varied considerably across the range of 
benzoic acid substrates though all were lower in activity when compared to 4-
methoxybenzoic acid (Table 1 and Fig. 3).17, 18 CYP199A4 had no observable NADH 
oxidation or product formation activity with 2-methoxybenzoic and 2,5-dimethoxybenzoic 
acids (Fig. S3a and b). CYP199A4 in the presence of 3-methoxybenzoic acid did oxidise 
NADH but no product from substrate oxidation could be detected via HPLC or GC-MS 
analysis (Fig. S3c) and similar results were obtained for benzoic acid (Fig. S3). Furthermore 
very little hydrogen peroxide was generated in these turnovers. The percentage of reducing 
NADH equivalents channelled into hydrogen peroxide formation was 2.2  0.7% for 3-
methoxybenzoic acid and 4.7  0.3% for benzoic acid (Table 1) suggesting the elevated 
NADH oxidation rate is most likely due to the oxidase uncoupling pathway. This presumably 
arises as the 3-methoxy substituent or any other CH bond is not close enough to the reactive 
iron-oxo intermediate to be oxidised.25, 26 Of the substrates which lack a 4-methoxybenzoic 
acid moiety only 3,5-dimethoxybenzoic acid yielded any observable product. However the 
rate of NADH oxidation is very slow and the levels of product formation are extremely low 
with a single product being observed by HPLC (Table 1 and Fig. 4a). In the absence of an 
authentic product standard the turnover was derivatised with BSTFA/TMSCl and analysed by 
GC-MS (Fig. 5a). The product has a mass of 312.1 AMU which corresponds to a doubly 
TMS-derivatised species arising from a single oxidative demethylation of the substrate to 
yield 3-hydroxy-5-methoxybenzoic acid (Scheme 1 and Fig. S4a). The observation of even a 
small amount of product with 3,5-dimethoxybenzoic acid is interesting as the related 3-
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methoxybenzoic acid is not oxidatively demethylated by CYP199A4 and this information 
when combined with the significantly different spin state shift on substrate binding suggests a 
different binding mode for these two molecules in the active site.  
In the CYP199A4 substrate-bound crystal structures with 4-methoxybenzoic, 4-
ethylbenzoic and 3,4-dimethoxybenzoic acids, (PDB codes: 4DO1, 4EGM and 4EGN, 
respectively) the benzoic acid components of the substrates are superimposed. The 
substituent in the para position is held over the heme iron for efficient oxidation while the 3-
methoxy substituent of 3,4-dimethoxybenzoic acid points away from the heme towards 
Phe182. Given that substrates which do not have a 4-methoxy substituent give rise to low 
levels of product formation it is likely that the other substituents, such as a 3-methoxy group, 
point away from the heme. In the case of 3,5-dimethoxybenzoic acid if one methoxy group 
points at Phe182 the other must be orientated towards the heme. Despite not sterically 
displacing the iron-bound water molecule and modifying the spin state, it is close enough to 
result in low levels of a single demethylated product. 3,5-Dimethoxybenzoic acid was docked 
into the substrate binding pocket of 4-methoxybenzoic acid-bound CYP199A4 (PDB: 
4DO1), minus the substrate, and energy minimised. Compared to the structure of 3,4-
dimethoxybenzoic acid and other analogues the benzoic acid moiety was tilted by 15 ° (Fig. 
6a). In this position the 3-methoxy methyl carbon is only 5.0 Å from the heme iron (the 
oxygen of the same methoxy group is 0.2 Å closer). The 3-methoxy carbon is also 2.8 Å from 
both Leu98, and the closest heme carbon atom and 3.0 Å from a heme nitrogen. The 5-
methoxy group points towards Phe182 with both the oxygen and methyl carbon being 2.9 Å 
from the closest atom of this residue (Fig. 6a). This altered binding orientation may explain 
the observation of an oxidative demethylation product, in contrast to 3-methoxybenzoic acid, 
while the long Fe-C (O-Me) distance gives rise to the reduced product formation rate, which 
is two orders of magnitude lower, compared to 4-methoxybenzoic acid (Fig. 6a). The altered 
12 
 
binding orientation of 3,5-dimethoxybenzoic acid is much less favourable, resulting in a 20-
fold decrease in binding and a 5000-fold decrease in activity relative to 4-methoxybenzoic 
acid.  
The oxidation of all the remaining substrates by CYP199A4 resulted in the formation 
of a single product arising through demethylation of a methoxy group at the para-position, or 
in the case of 3,4-(methylenedioxy)benzoic acid, demethenylation of the methylenedioxy 
group (Scheme 1). The products were identified via co-elution of authentic standards via 
HPLC or GC-MS analysis of the trimethylsilyl derivatives (Fig. 4, and S3). Levels of product 
formation were determined using HPLC or GC-MS after calibrating with the product 
standards.  
The CYP199A4 catalysed turnover of 6-methoxynicotinic acid displayed a NADH 
oxidation rate of 353 nmol (nmol-CYP)−1 min−1 (Table 1 and Fig. 3), which demonstrates the 
pyridine heterocyclic ring has a detrimental effect on the enzyme’s activity despite the 
substrate binding data indicating that 6-methoxynicotonic acid can bind effectively to the 
CYP199A4 enzyme. The product was confirmed as arising from oxidative demethylation via 
co-elution of the turnover with an authentic sample of 6-hydroxynicotinic acid with the 
turnover mixture via HPLC (Fig. 4b). GC-MS analysis of the BSTFA/TMSCl-derivatised 
turnover mixture yielded product of the predicted mass (m/z of 283.2 AMU vs. the expected 
m/z of 283.1 AMU). There was no evidence of N-oxide formation via GC-MS or HPLC. The 
product formation rate was 286 nmol (nmol-CYP)−1 min−1 indicating that the coupling of 
NADH reducing equivalents to product formation was high (81%). Therefore the four-fold 
lower activity of the 6-methoxynicotinic acid compared to 4-methoxybenzoic acid is due to 
slower turnover rate of the catalytic cycle. The incorporation of a nitrogen atom meta to the 
carboxylate group in the aromatic ring (ortho to the methoxy group) results in a lower 
activity. This nitrogen contains a non-bonded lone pair which is not part of the aromatic ring 
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and the nitrogen is considered to be electron withdrawing. The substrate may be orientated 
with the nitrogen either directed towards the heme ring or pointing at the Phe182 and Phe185 
residues. If it was directed towards the heme iron it would be expected to be a similar 
distance from the iron as the C3 carbon of 4-methoxybenzoic acid (5.1 Å). Docking of the 6-
methoxynicotinic acid substrate in the CYP199A4 active site with the nitrogen in this 
position, followed by energy minimisation, resulted in a structure where this nitrogen was 
only 5.2 Å from the heme iron (Fig. 5b). This compares to the 6-methoxy carbon which is 
only 3.9 Å away. If the nitrogen is directed towards the heme it could interfere with the 
formation or cleavage of heme iron-oxygen adducts. We note the lack of any N-oxide 
formation which would be evidence of the substrate being orientated with the nitrogen closer 
the heme. However we cannot yet rule out an altered substrate binding orientation. The N-
containing heterocycle is less sterically hindered than a meta substituted benzene ring and 
therefore 6-alkyl substituted nicotinic acid derivatives could be useful probes to further 
investigate the partition between desaturation and hydroxylation of alkyl side chains by 
CYP199A4 using the electron withdrawing pyridine ring. 
2,4-Dimethoxybenzoic acid is efficiently turned over to yield one product which was 
confirmed by GC-MS to correspond to a single demethylation (Fig. 5b and S3d). Based on all 
the previous data obtained for substituted 4-methoxybenzoic acids with CYP199A4 it is 
likely that the product is a result of oxidative demethylation para to the carboxyl group to 
yield 2-methoxy-4-hydroxybenzoic acid (Fig. S5). The turnover activity and coupling of 2,4-
dimethoxybenzoic acid with CYP199A4 were lower than 3,4-dimethoxybenzoic acid. Both 
2- and 3-hydroxy-4-methoxybenzoic acids were turned over by CYP199A4 generating a 
single product (2,4- and 3,4-dihydroxybenzoic acids, respectively, Fig. 4c and Fig. S3e). The 
product formation rate of the 3-hydroxy analogue was higher than that of 2-hydroxy-4-
methoxybenzoic acid (Table 1). This is in line with the NADH oxidation activities but not the 
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tighter binding of the 2-hydroxy analogue. The activity and coupling of the substrates with a 
hydroxyl or methoxy substituent at the 3-position were higher than those with the equivalent 
substitutions at the 2-position (Table 1). 
Certain plant P450 enzymes, such as CYP719A can catalyse the oxidative cyclisation 
of ortho-hydroxymethoxy-containing substrates resulting in the formation of a 
methylenedioxy ring. This reaction is important, for example, in isoquinoline alkaloid 
biosynthesis.27, 28 There was no evidence for the formation of a methylenedioxy bridge in the 
CYP199A4 catalysed turnover of 3-hydroxy-4-methoxybenzoic acid. Methylenedioxy-bridge 
formation is proposed to occur in the plant enzymes by P450-dependent hydroxylation of the 
methoxy group yielding a hemiacetal which cyclises to form the methylenedioxy bridge by 
an ionic mechanism, involving a methylene oxonium ion intermediate (Scheme 2). The 
evidence for this mechanism is that no oxygen is incorporated into the product. The 
hemiacetal precursor to ring formation is the same as that which would be generated in the 
oxidative demethylation reaction of 3-hydroxy-4-methoxybenzoic acid. In CYP199A4 3-
hydroxy-4-methoxybenzoic acid may be bound in a similar fashion to 3,4-dimethoxybenzoic 
acid with the substituent in the 3-position pointing away from the heme iron (Fig. S5). In this 
orientation the methyl of the 4-methoxy group points towards the heme iron and away from 
the 3-hydroxy group allowing rapid hemiacetal formation and demethylation rather than 
methylenedioxy ring formation. If the hydroxy group points towards the heme it is located 
only 4.3 Å from the iron. The plant P450 enzymes, which carry out this transformation, must 
bind their substrates in such a way relative to the heme iron-oxo intermediate which favours 
this reaction over oxidative demethylation or convert the intermediate radical directly to the 
cationic methylene oxonium ion. 
As a substrate 3,4-(methylenedioxy)benzoic acid generates a single monooxygenase 
product, 3,4-dihydroxybenzoic acid (Fig. 4d). The demethenylation reaction proceeds with 
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lower activity than the demethylation of 4-methoxybenzoic acid, 3,4-dimethoxybenzoic acid 
and 3-hydroxy-4-methoxybenzoic acid. This would be unexpected if hydrogen abstraction 
was the rate determining step due to the favourable electronic effect of two oxygen atoms. 
The substrate must be held in the substrate binding pocket with the methylene C-H bonds 
located in a less favourable position for attack by compound I compared to the methyl 
moieties of the methoxy groups of the other substrates. This may be due to the constrained 
nature of the five membered ring resulting in the methylene group being bound further away 
from the heme iron. Docking of 3,4-(methylenedioxy)benzoic acid into the substrate binding 
pocket followed by energy minimisation indicated it could bind in a similar orientation to 
indole-6-carboxylic acid (PDB: EGO) which places the methylenedioxy bridge only 4.0 Å 
from the heme iron (Fig. 6c), compared to 3.8 Å for the methoxy carbon of 4-
methoxybenzoic acid (PDB: 4DO1). However the substrate could also bind in a similar 
fashion to 3,4-dimethoxybenzoic acid (PDB: 4EGN) which would place the methylene 
carbon 5.7 Å away from the heme iron (Fig. 6c and Fig. S5).  
Demethenylation is thought to occur by a three-step process involving initial 
oxidation of the methylene carbon, followed by a rearrangement and hydrolysis generating 
formic acid rather than formaldehyde, which is produced in oxidative demethylation (Scheme 
3). To confirm this we analysed the turnovers of 3,4-methylenedioxy benzoic acid and 4-
methoxybenzoic acid derivatives for the presence of formaldehyde and formic acid. The 
turnovers of 4-methoxybenzoic, 3,4-dimethoxybenzoic and 3-hydroxy-4-methoxybenzoic 
acids generated formaldehyde, as measured by the Purpald assay, in line with the levels of 
product observed (Fig. 7 and Fig. S6). Nugatory levels of formic acid were observed in these 
assays (formate assay, Megazyme). The turnover of 3,4-(methylenedioxy)benzoic acid 
showed the opposite results with low levels of formaldehyde but significant quantities of 
formic acid being produced in agreement with the mechanism proposed. To confirm the 
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absence of 3,4-(methylenedioxy)benzoic acid in the turnover of 3-hydroxy-4-
methoxybenzoic acid, which may have been further oxidised to 3,4-dihydroxybenzoic acid, 
we also analysed this turnover reaction for the generation of formic acid as well as 
formaldehyde. Only formaldehyde was found to be present and the lack of any formic acid 
rules out further processing of any generated methylenedioxy compounds during CYP199A4 
mediated turnover of 3-hydroxy-4-methoxybenzoic acid.  
Kinetic isotope studies on the reaction of mammalian P450s on methylenedioxy 
containing drug molecules have led to the proposal that an alternative pathway driven by 
peroxide based chemistry may compete with the mechanism outlined (Scheme 3).29 The 
levels of uncoupling in the CYP199A4 catalysed reaction are relatively low therefore 
CYP199A4 could be used to study the mechanism of demethenylation in more detail. In 
addition there was no evidence of inhibition of turnover rates after initial oxidation of the 
methylenedioxy group (Fig. 4) as has been observed in the CYP2A6 metabolism of 
paroxetine which is proposed to be due to binding of a carbene species to the heme iron 
(Scheme 3 and Fig. 3).30 
Overall we have shown that CYP199A4 catalyses the efficient oxidative 
demethylation of a range of para-substituted benzoic acid derivatives with concomitant 
formation of formaldehyde. Substituents of moderate size at the ortho- and meta-positions 
can be tolerated and oxidative demethenylation, which generates a diol and formic acid, is 
also catalysed efficiently by this enzyme. The binding of the benzoic acid substrates in 
CYP199A4 must be very tightly controlled as oxidation only occurs on the para substituent. 
With other P450s blocking the position of the closest CH bonds, where hydroxylation is 
preferred, often leads to oxidation at another position often at an adjacent carbon.31, 32 This 
makes CYP199A4 and para substituted benzoic acids an ideal enzyme-substrate 
combinations to ensure that only the desired functional groups is oxidised. This could be 
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utilised for selective demethylation or hydroxylation reactions on multiply substituted 
substrates. This also makes para substituted benzoic acids ideal substrate scaffolds with 









General reagents, organic substrates and N,O-bis(trimethylsilyl)trifluoroacetamide with 
trimethylchlorosilane (BSTFA/TMSCl, 99:1) were from Sigma-Aldrich, TCI or Merck, 
Australia. Buffer components, NADH and isopropyl--D-thiogalactopyranoside (IPTG) were 
from Astral Scientific, Australia. UV/Vis spectra and spectroscopic activity assays were 
recorded at 30  0.5 °C on an Agilent CARY-60 or Varian CARY-5000 spectrophotometer.  
Enzymes and molecular biology 
General DNA and microbiological experiments were carried out by standard methods.33 The 
expression and purification of CYP199A4, HaPux, and HaPuR have been described 
elsewhere.14, 17, 34 Proteins were stored at –20 °C in 50 mM Tris, pH 7.4 containing 50% v/v 
glycerol. Glycerol was removed immediately before use by gel filtration on a 5-mL PD-10 
column (GE Healthcare, UK) by eluting with 50 mM Tris, pH 7.4. The CYP199A4 protein 
concentration was calculated using ε419 = 119 mM
−1cm−1.17, 23  
Activity assays 
In vitro NADH turnover rate assays were performed with mixtures (1.2 mL) containing 50 
mM Tris, pH 7.4, 0.5 μM CYP199A4, 5 μM HaPux, 0.5 μM HaPuR and 100 μg mL1 bovine 
liver catalase. The buffer solution was oxygenated before use and the mixture equilibrated at 
30 °C for 2 min. Substrates were added from a 100 mM stock solution in ethanol to a final 
concentration of 1 mM. NADH was added to ca. 320 μM (final A340 = 2.00) and the 
absorbance at 340 nm was monitored. The rate of NADH oxidation was calculated using ε340 
= 6.22 mM–1cm–1. 
Substrate binding: spin state determination and binding titrations 
The high-spin heme content was estimated (to approximately ±5%) by comparison with a set 
of spectra generated from the sum of the appropriate percentages of the spectra of the 
19 
 
substrate-free (>95% low-spin, Soret maximum at 418 nm) and camphor-bound (>95% high-
spin, Soret maximum at 392 nm) forms of WT CYP101A1. 
For dissociation constant determination CYP199A4 was diluted to 0.5 – 2.0 µM using 
50 mM Tris, pH 7.4, in 2.5 mL and 0.5 – 2 µL aliquots of the substrate were added using a 
Hamilton syringe from 1, 10 or 100 mM stock solutions in ethanol. The maximum peak-to-
trough difference (ΔA) in absorbance between 700 nm and 250 nm was recorded. Further 
aliquots of substrate were added until the peak-to-trough difference did not change. The 
dissociation constants, Kd, were obtained by fitting ΔA against total substrate concentration 
[S] to a hyperbolic function: 
 
where ΔAmax is the maximum absorbance difference. Several substrates exhibited tight 
binding, with Kd < 2 µM. In these instances the data were fitted to the tight binding quadratic 
equation:35  
  
where ΔAmax is the maximum absorbance difference and [E] is the enzyme concentration. 
Analysis of metabolites 
After the NADH had been consumed in substrate oxidation incubations, 132 μL of the 
reaction mixture was mixed with 2 μL of an internal standard solution (10 mM 9-
hydroxyfluorene in ethanol). This was mixed with 66 μL of acetonitrile before analysis by 
HPLC. Reverse phase HPLC was performed using an Agilent 1260 Infinity pump equipped 
with an Agilent Eclipse Plus C18 column (250 mm x 4.6 mm, 5 µm) and an autoinjector and 
UV detector. A gradient, 20 - 95%, of acetonitrile in water (both containing trifluoroacetic 




















The retention times for the substrates and products were as follows; 2-methoxybenzoic acid, 
11.9 min; 3-methoxybenzoic acid, 13.0 min; 4-methoxybenzoic acid, 12.5 min; 4-
hydroxybenzoic acid, 6.8 min; 3-hydroxybenzoic acid, 8.2 min; 6-methoxynicotinic acid, 7.0 
min; 6-hydroxynicotinic acid, 5.1 min; 2-hydroxy-4-methoxybenzoic acid, 13.9 min; 2,4-
dihydroxybenzoic acid, 8.5 min; 3-hydroxy-4-methoxybenzoic acid, 7.9 min; 3,4-
dihydroxybenzoic acid, 5.3 min; 3,4-(methylenedioxy)benzoic acid, 12.2 min; 3,4-
dimethoxybenzoic acid, 12.0 min; 3-methoxy-4-hydroxybenzoic acid, 7.5 min; 2-methoxy-4-
hydroxybenzoic acid, 7.4 min; 2,4-dimethoxybenzoic acid 11.9 min; 3,5-dimethoxybenzoic 
acid 13.8 min; 3-hydroxy-5-methoxybenzoic acid 9.9 min; 2,5-dimethoxybenzoic acid, 13.7 
min.  
For gas chromatography analysis 990 μL of the reaction mixture was mixed with 10 
μL of an internal standard solution (10 mM 9-hydroxyfluorene in ethanol) and 2 μL of 
concentrated HCl. The mixture was extracted three times with 400 μL of ethyl acetate and the 
organic extracts were combined and dried over MgSO4. Solvent was evaporated under a 
stream of dinitrogen and the sample dissolved in 200 μL acetonitrile. Excess (25 μL) BSTFA 
+ TMSCl (99:1) was added and the mixture left for at least 120 min to produce the 
trimethylsilyl ester of the carboxylic acid group and trimethylsilyl ether of the alcohol, if 
formed. The resultant mixtures were used directly for GC analysis. The oven temperature 
was held at 120 ºC for 3 min and then increased at 10 ºC min1 up to 220 ºC before being 
held for a further 7 min. The retention times for the trimethylsilyl (TMS) derivatised 
substrates and products were as follows; 4-methoxybenzoic acid, 7.8 min; 4-hydroxybenzoic 
acid, 11.2 min; 6-methoxynicotinic acid, 7.8 min; 6-hydroxynicotinic acid, 10.2 min; 2,4-
dimethoxybenzoic acid, 14.2 min; 2-hydroxy-4-methoxybenzoic acid, 16.1 min; 3,5-
dimethoxybenzoic acid, 13.7 min; 3-hydroxy-5-methoxybenzoic acid, 15.2 min. 
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Products were calibrated against authentic product standards where available. When 
authentic samples were not available the coupling was estimated based on the closest 
available compound from those above. For example for 2-methoxy-4-hydroxybenzoic acid, 
for which no authentic standard was available, the product peaks were calibrated against both 
the substrate (2,4-dimethoxybenzoic acid) and 2,4-dihydroxybenzoic acid to determine the 
HPLC detector response (the responses of both were very similar). These were then used to 
estimate the concentration of the product peak.  
Formaldehyde, formic acid and hydrogen peroxide assays 
The formaldehyde content of turnovers was determined using mixtures (600 µL) containing 
Tris buffer, pH 7.4, 50 mM (312 µL), the turnover mixture (240 µL) and Purpald (48 µL 
from 168 mM stock in 2M NaOH). The reaction of formaldehyde and Purpald was allowed to 
develop with shaking for 15 min before quantifying the formaldehyde Purpald complex 
(Scheme S1) using the absorbance at 550 nm and subsequent comparison to a calibration 
curve (Fig. S6).36 
The formic acid content was determined using a formic acid assay kit from 
Megazyme. The turnover (1.1 mL), H2O (1.0 mL), phosphate buffer (pH 7.6, 0.2 mL) and β-
NAD (0.2 mL) were combined and equilibrated for 5 min. The absorbance at 340 nm was 
measured and formate dehydrogenase (50 µL) was added to consume formic acid and form 
NADH; this was allowed to react for 15 min. The increase in absorbance at 340 nm was used 
to quantify the formic acid. The concentration of hydrogen peroxide formed by uncoupling 
during NADH oxidation was determined by the horseradish peroxidase/phenol/4-
aminoantipyrine assay as described previously.37  
Docking Studies 
Ligand coordinates and restraints were created using PHENIX eLBOW (PMID: 19770504). 
Ligands were initially docked manually into the active site of CYP199A4 (PDB: 4DO1), with 
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the 4-methoxybenzoic acid removed, using Coot (PMID: 20383002). Each model was 
individually subjected to regularization and model refinement with ICM-Pro (to carry out 
energy minimization, optimize model geometry, and alleviate clashing side chains). The 
protein-ligand complexes were subjected to 300 rounds of Cartesian MMFF energy 
minimization using ICM Pro (Molsoft, LLC). Side chains were globally optimized and the 




The substrate range of CYP199A4 has been assessed using a range of methoxybenzoic acid 
derivatives. A methoxy group at the para position is essential for optimal activity. 
Substitutions at other positions or the insertion of a heteroatom in the ring can be tolerated 
but the activity is reduced. CYP199A4 does not catalyse methylenedioxy ring formation with 
3-hydroxy-4-methoxybenzoic acid but does catalyse oxidative demethenylation of 3,4-
(methylenedioxy)benzoic acid. As a result the biocatalytic scope of CYP199A4 has been 
determined and this knowledge can be used to improve substrate binding and turnover of 
CYP199A4 with non-natural substrates through protein engineering. Probes which 
complement the size and shape of the substrate binding pocket of CYP199A4 can also be 
designed. This will minimise competing uncoupling pathways and allow the tight control the 
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Table 1 Substrate binding parameters and catalytic turnover activity data for CYP199A4 with various substrates. The data are given as mean  
S.D. with n  3. The reaction mixtures (50 mM Tris, pH 7.4) contained 0.5 μM P450, 5 μM HaPux and 0.5 μM HaPuR. Rates are given as nmol 
(nmol-CYP)−1 min−1.  
 
Substrate % HS Kd (μM) N[a] PFR[b] Coupling (%)[c] 
4-methoxybenzoic acid 95%      0.28  0.01     1340  28    1219  120 91  2 
2-methoxybenzoic acid  10%         n.m.d -e -f -f 
3-methoxybenzoic acid  40%    69  2.0      498  5.0 -f   -f, g 
3,4-dimethoxybenzoic acid  70%    29.5  3.1     807  35    626  100 77  9 
2,4-dimethoxybenzoic acid  90%    47  1.0     664  32     384  21 58  1 
3,5-dimethoxybenzoic acid  10% 1500  200       49  2.0         7  2 14  4 
2,5-dimethoxybenzoic acid  <10%         n.m.d -e -f -f 
3-hydroxy-4-methoxybenzoic acid  90%      1.7  0.09      847  60      663  75 75  8 
2-hydroxy-4-methoxybenzoic acid 95%      0.16  0.01      483  32      271  20 56  4 
6-methoxynicotinic acid 95%      0.46 0.05       353  6.0      286  32 81  8 
3,4-(methylenedioxy)benzoic acid  70%      0.17  0.05       265  7.2      158  19 59  7 
benzoic acid  30%     13 ± 0.2       257 ± 2.0 -f -f, h 
      
[a] N: NADH turnover rate. [b] PFR: product formation rate. [c] Coupling is the percentage of NADH consumed in the reaction that led to the 
formation of product arising from substrate oxidation. [d] Not reported due to low levels spin state shift preventing accurate determination (> 1.5 
mM) . [e] No significant NADH oxidation activity above the leak rate. [f] no detectable levels of product formation. [g] Hydrogen peroxide 
levels were only 8.5  1.4 M (2.2  0.7%) of the turnover. By way of comparison 4-methoxybenzoic acid turnover generated 5.5  0.5 M 




Scheme 1 The products formed from the CYP199A4 enzyme turnovers of the benzoic acid 












Scheme 3 Proposed reaction mechanism for methylenedioxy deprotection by mammalian P450 
enzymes. Included is the proposed formation of the carbene intermediate which can act as an 












Figure 1b Spin state shift of CYP199A4 (red; substrate-bound CYP199A4, black; substrate-free 
CYP199A4) with the substrates (i) 3-methoxybenzoic acid (ii) 2,4-dimethoxybenzoic acid (iii) 3,4-
(methylenedioxy)-benzoic acid. 
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Figure 2 Dissociation constant analysis of selected substrates with CYP199A4 (a) 3-
methoxybenzoic acid (b) 3,5-dimethoxybenzoic acid (c) 2-hydroxy-4-methoxybenzoic acid. 
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Figure 3 (a) NADH oxidation kinetic assays with 3-hydroxy-4-methoxybenzoic acid (black), 2-
hydroxy-4-methoxybenzoic acid (red) and 3,4-(methylenedioxy)benzoic acid (blue). (b) NADH 









Figure 4 HPLC analysis of CYP199A4 substrate turnovers. Shown are (a) 3,5-dimethoxybenzoic 
acid  (b) 6-methoxynicotinic acid (c) 3-hydroxy-4-methoxybenzoic acid (d) 3,4-(methylenedioxy)-
benzoic acid. A gradient, 20 - 95%, of acetonitrile (with trifluoroacetic acid, 0.1%) in water (TFA, 
0.1%) was used and the absorbance was monitored at 254 nm. 
 
(a) 3,5-dimethoxybenzoic acid  (turnover in black, substrate control in blue) 
 



























(b) 6-methoxynicotinic acid (turnover in black, substrate control in blue and 6-hydroxynicotinic acid 
control in red) 
 
































(c) 3-hydroxy-4-methoxybenzoic acid (turnover in black, substrate control in blue and 3,4-
dihydroxybenzoic acid control in red) 
 





























(d) 3,4-(methylenedioxy)benzoic acid (turnover in black, substrate control in blue and 3,4-
dihydroxybenzoic acid control in red) 
 

































Figure 5 GC-MS analysis of CYP199A4 substrate turnovers. Shown are (a) 3,5-dimethoxybenzoic 




































































Figure 6 Structures of CYP199A4 with different substrates docked in the active site after energy 
minimisation. Two orientations are shown where a substitution made the substrate unsymmetrical 
around the C1-C4 axis. (a) 3,5-dimethoxybenzoic acid and a comparison of the orientation of 3,5-
dimethoxybenzoic acid with 3,4-dimethoxybenzoic acid (PDB: 4EGN), (b) 6-methoxynicotinic acid 
with the pyridine nitrogen pointing towards or away from the heme and (c) 3,4-
(methylenedioxy)benzoic acid and a comparison of 6-indolecarboxylic acid (PDB: 4EGO) with 3,4-
(methylenedioxy)benzoic acid bound with the methylenedioxy ring orientated towards the heme. 
Distances are provided in the ESI as are docking studies of the other substrates (Fig. S5) 
(a) 
   
(b) 
   
(c) 
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Figure 7 Purpald assay for formaldehyde formation. Black: 4-methoxybenzoic acid, red: 3,4-
dimethoxybenzoic acid, blue: 3,4-(methylenedioxy)benzoic acid, pink: 3-hydroxy-4-
methoxybenzoic acid. The amount of formaldehyde measured was in line with the level of product 
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